Protagenic Therapeutics, Inc.\new Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
Protagenic Therapeutics, Inc.\new (PTIX) had Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number of 1.54 million shares as of 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber · last filed 2023-03-31
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 1.54M shares.
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 6.15M shares.
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 6.15M shares.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 6.15M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number as first filed |
|---|---|---|
| 2022-12-31 | 1.54M shares 10-K · filed 2023-03-31 | |
| 2022-09-30 | 6.15M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 6.15M shares 10-Q · filed 2022-08-11 | |
| 2022-03-31 | 6.15M shares 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 1.53M shares 10-K · filed 2023-03-31 | 6.13M shares 10-K · filed 2022-04-07 |
| 2021-09-30 | 6.13M shares 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 6.13M shares 10-Q · filed 2021-08-16 | |
| 2021-03-31 | 3.48M shares 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 1.00M shares 10-K · filed 2023-03-31 | 4.01M shares 10-K · filed 2021-03-25 |
| 2020-09-30 | 4.01M shares 10-Q · filed 2020-11-16 | |
| 2020-06-30 | 3.91M shares 10-Q · filed 2020-08-14 | |
| 2020-03-31 | 3.83M shares 10-Q · filed 2020-06-18 | |
| 2019-12-31 | 3.83M shares 10-K · filed 2021-03-25 | |
| 2019-09-30 | 3.83M shares 10-Q · filed 2019-11-14 | |
| 2019-06-30 | 3.83M shares 10-Q · filed 2019-08-14 | |
| 2018-12-31 | 3.83M shares 10-K · filed 2021-03-25 | |
| 2017-12-31 | 3.83M shares 10-K · filed 2020-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |